One of the major challenge路鐘s in the clinic for th好哥e treatment of various disease問風s is the ability to consistentl體藍y deliver therapeutics at effica黑裡cious levels. Recently, researcher山線s in the Division of Hematology暗從 and Oncology at Nationwid近能e Children’s Hospita們媽l engineered a single dose章身 of gene therapy usi師能ng adeno-associated virus (AAV) to sa身南fely express a therapeuti嗎就c protein in the bloo海快dstream, which resulted in tumo照雨r regression and demonstrated 公林its efficacy as a會短 treatment for lymphoma.
Bispecific antib姐說odies and CAR T但亮 cells have recen物問tly gained populari謝請ty as therapeutics for tr窗議eating hematological malignancies;事月 however, their use in t懂冷he clinic has been hinde舞司red by challenges with delivery and了生 manufacturing. Dr. Timothy C和吧ripe and his team were 生嗎able to design secreted bispe她飛cific antibodies targeting ca師了ncer and immune cells delivered by a票森 single dose of樂區 AAV that were expre開行ssed at sustained levels fo白小r up to a year.水白 This proof of p機人rinciple study 小說demonstrated that t木男heir engineered genet飛費ic therapy is effective in treating a懂開 humanized-mouse model線吧 of lymphoma without advers秒人e toxicity.
Further, Dr. Cripe and 姐到the team at Nationwide Childr草小en’s Hospital wer國歌e able to optimize thei志林r gene therapy design by mo可日difying their AAV serotype, e雪微ngineering their promoter, and 車答by adding a post-transcriptional r公空egulatory element. In a購綠ddition, the team d關現eveloped an inducible versio飛理n of their construct that was also ab樹還le to target KRAS看時, a gene frequently mutated in cancers.人很 Overall, this study demon腦關strated the potential e事作fficacy of a single dose of gene ther劇放apy in treating canc讀能er.
Construction of AAV and vecto的鐵rs was enabled by Vec些姐torBuilder’s online Vector Design Studio. VectorBuilder offers custom費西 and pre-made AAV vectors that can be p來通ackaged into a variety of serot呢綠ypes for your gene delivery needs—click here to learn more. Contact us to find out more跳短 or use our awa熱慢rd-winning online plat業山form to design and ord筆又er custom vectors specific to 好的your research needs.
---
Source (https://www.science.or明和g/doi/10.1126/sciadv.abm1890)
Cripe TP, Hutzen B, Currier 事還MA, Chen CY, Glaspell AM, Sulliva文厭n GC, Hurley JM, Deig樹雪hen MR, Venkataramany AS, Mo X, Stanek遠她 JR, Miller AR, Wijeratne S, 拍我Magrini VJ, Mardis ER, Mendell JR,銀看 Chandler DS, Wang PY. Leveragi信妹ng Gene Therapy to Ac地北hieve Long-Term Continuous o購匠r Controllable Expr很書ession of Bioth票身erapeutics. Science Advan討近ces. 2022 Jul 13.